DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Bioprocess Technology Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Bioprocess Technology Market is poised to grow at a CAGR of around 13.6% over the next decade to reach approximately $125.71 billion by 2025.
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies for the existing players, new entrants and the future investors. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
- Rise in R&D expenditure in Developed nations
- Growing count of New Drug Launches
- Recent Technological Developments in Bioprocess Technology
- Growth Opportunities/Investment Opportunities
4 Top 10 Bioprocess Technology Market, By Type
- Cell Expansion
- Flow Cytometry
- Biologics Safety Testing
- Cell Line Development
- Tangential Flow Filtration
- Cell Counting
- Virus Filtration
- Cell Culture
- Pyrogen Testing
- Single-Use Bioprocessing
5 Top 10 Bioprocess Technology Market, By Geography
6 Key Player Activities
7 Leading Companies
- GE Healthcare
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Lonza Group AG
- Merck Millipore
- Sartorius Stedim Biotech S.A
- Corning, Inc.
- Bio-Rad Laboratories
- Charles River Laboratories
For more information about this report visit http://www.researchandmarkets.com/research/qslvfg/global_bioprocess